EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?

Daniel Rivas, Alejandro de la Torre-Luque, Elena Moreno-Olmedo, Paloma Moreno, Vladimir Suárez, Ana Serradilla, Gregorio Arregui, David Álvarez, Morena Sallabanda, Antonio Lazo, María Isabel Núñez, Escarlata López

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05140-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal of Urology, 2024. Verfasst von Daniel Rivas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, GenesisCare, Málaga, Spain. Hauptthemen laut MEDLINE: Radiosurgery, Kidney Neoplasms, Adrenal Gland Neoplasms, Carcinoma, Renal Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Granada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Stereotactic body radiotherapy (SBRT) has become an excellent non-invasive alternative for many patients with primary renal cell carcinoma (RCC) and adrenal malignancies (AM). The aims of this study were to analyse how tumor-, patient- and treatment-related factors may influence the outcomes and side effects of SBRT and to assess its benefits as an alternative to surgery.

Methods

This retrospective, multicenter study included 25 lesions in 23 patients treated with SBRT using different devices (LINAC, CyberKnife ® and Tomotherapy ® ). A multivariate linear regression was used for the statistical study.

Results

Local control time was higher than six months in more than 87% of patients and treatment response was complete for 73.68%. There was an overall 2-year survival of 40% and none of the deaths were secondary to renal or adrenal local progression. Patients treated with lower total radiation dose (mean [m] = 55 Gy) but less fractions with more dose per fraction (> 8.5 Gy) showed better outcome. Patients with previous chemotherapy and surgery treatments also showed higher complete response and disease-free survival (> 6 months).

Conclusions

This study highlights the importance of ultra-hypofractionated regimens with higher doses per session. Thus, the referral of patients with RCC and AM to Radiotherapy and Oncology departments should be encouraged supporting the role of SBRT as a minimally invasive and outpatient treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryKidney NeoplasmsAdrenal Gland NeoplasmsCarcinoma, Renal CellHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTreatment OutcomeAged, 80 and overDose Fractionation, RadiationAdultSurvival Rate

Stichwörter der Autor:innen

Adrenal malignant lesionRenal malignant lesionStereotactic ablative radiotherapy (SABR)Stereotactic body radiotherapy (SBRT)Toxicity

Autor:innen und Institutionen

  • Department of Radiation Oncology, GenesisCare, Málaga, Spain.
  • Clinical Medicine and Public Health, University of Granada, Granada, Spain.
  • Department of Legal Medicine, Psychiatry and Pathology, School of Medicine, Complutense University of Madrid. CIBERSAM ISCIII, Madrid, Spain.
  • Department of Stereotactic and MR-guided Radiotherapy, Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Genesiscare, Oxford, UK.
  • Independent author, Madrid, Spain.
  • Department of Radiation Oncology, Complejo Hospitalario de Jaen, Jaen, Spain.

Förderung

  • Universidad de Granada

Zitieren

APA

Rivas, D., de la Torre-Luque, A., Moreno-Olmedo, E., Moreno, P., Suárez, V., Serradilla, A., Arregui, G., Álvarez, D., Sallabanda, M., Lazo, A., Núñez, M. I., & López, E. (2024). Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?. World Journal of Urology. https://doi.org/10.1007/s00345-024-05140-9

Vancouver

Rivas D, de la Torre-Luque A, Moreno-Olmedo E, Moreno P, Suárez V, Serradilla A, et al. Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?. World Journal of Urology. 2024. doi:10.1007/s00345-024-05140-9

BibTeX
@article{Rivas2024,
  author = {Rivas, Daniel and de la Torre-Luque, Alejandro and Moreno-Olmedo, Elena and Moreno, Paloma and Suárez, Vladimir and Serradilla, Ana and Arregui, Gregorio and Álvarez, David and Sallabanda, Morena and Lazo, Antonio and Núñez, María Isabel and López, Escarlata},
  title = {Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05140-9}
}
Kostenlos starten →